Ubs Asset Management Americas Inc Rx Sight, Inc. Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Rx Sight, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 63,552 shares of RXST stock, worth $3.11 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,552
Previous 30,823
106.18%
Holding current value
$3.11 Million
Previous $1.59 Million
140.59%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RXST
# of Institutions
231Shares Held
31.3MCall Options Held
57.8KPut Options Held
12.5K-
Ra Capital Management, L.P. Boston, MA3.69MShares$181 Million3.35% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$117 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$98.2 Million0.0% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ1.74MShares$84.9 Million0.35% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.33MShares$65.2 Million0.13% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.35B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...